Home › Research › Health systems and care delivery
Benefits and Cost of a $35 Insulin Cost-Sharing Cap for Medicare Patients
Kao-Ping Chua, Joyce M. Lee, Joshua E. Tucker, Dominique Seo, Rena M. Conti. Not indexed, 2022-01-07
Topic: Risk, prevention and care in population studies
Plain-language summary
Additionally, it is unknown whether the benefits of this cap would vary between Medicare patients with type 1 versus type 2 diabetes. RESULTS The IQVIA analysis included 2,227,229 patients who only had dispensed insulin prescriptions paid by Medicare in 2019. The $35 cap would benefit a higher proportion of patients with type 1 diabetes (64.0%) compared with patients with type 2 diabetes (59.4%). Among patients with type 1 diabetes who would benefit from the cap, annual savings would be greater ($284) compared with their counterparts with type 2 diabetes ($231; p<.001 in adjusted analyses for all comparisons).
What this study adds
Evidence grade: Moderate
This is a cross-sectional study of 2,227,229 participants. This study estimated how many Medicare patients with diabetes would benefit from a $35 monthly cap on insulin cost sharing and how much they would save. Reported effect size: 39.0%; 4.5%; 95.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chua, K.-P., Lee, J. M., Tucker, J. E., Seo, D., & Conti, R. M. (2022). Benefits and Cost of a $35 Insulin Cost-Sharing Cap for Medicare Patients. https://doi.org/10.1101/2022.01.06.22268864
Vancouver
Chua K.-P, Lee JM, Tucker JE, Seo D, Conti RM. Benefits and Cost of a $35 Insulin Cost-Sharing Cap for Medicare Patients. 2022. doi:10.1101/2022.01.06.22268864.
BibTeX
@article{chua2022-f2eb762d,
author = {Chua, Kao-Ping and Lee, Joyce M. and Tucker, Joshua E. and Seo, Dominique and Conti, Rena M.},
title = {{Benefits and Cost of a \$35 Insulin Cost-Sharing Cap for Medicare Patients}},
year = {2022},
doi = {10.1101/2022.01.06.22268864},
url = {https://doi.org/10.1101/2022.01.06.22268864}
}
Built from the record alzhub holds for this paper, not looked up. This record has no journal, so the citation leaves it out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Additionally, it is unknown whether the benefits of this cap would vary between Medicare patients with type 1 versus type 2 diabetes.
- RESULTS The IQVIA analysis included 2,227,229 patients who only had dispensed insulin prescriptions paid by Medicare in 2019.
- The $35 cap would benefit a higher proportion of patients with type 1 diabetes (64.0%) compared with patients with type 2 diabetes (59.4%).
- Among patients with type 1 diabetes who would benefit from the cap, annual savings would be greater ($284) compared with their counterparts with type 2 diabetes ($231; p<.001 in adjusted analyses for all comparisons).
Why it matters
This study estimated how many Medicare patients with diabetes would benefit from a $35 monthly cap on insulin cost sharing and how much they would save. It provides no information on treating, curing or preventing Alzheimer's disease.
Study details
- Study designcross-sectional
- Participants2,227,229
- Effect size39.0%; 4.5%; 95.6%
- Evidence strengthModerate
How this study scored 48/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it. We have no data on journal's citation record and impact for its field and year, so those were left out: it earned 43 of the 90 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Not indexed) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 2,227,229 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Rena M. Conti: h-index 37 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Michigan: institution h-index 2,240 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 43 / 90 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 43 of the 90 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery from nearby years
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.